Oman imports 95.4% of the medicines it uses. It also offers a 30% price preference for locally manufactured products, 20% for products packaged locally, and advance purchase agreements covering up to 30% of Ministry of Health requirements.
Most companies entering Oman assemble a local agent, a regulatory consultant, a distributor and a promotion team separately. We are all four.
We assess your product against Oman's tender data and price file, and tell you whether it can win here.
Dossier, eCTD submission, GMP and CPP handling, deficiency responses and pricing committee — as your local agent.
Price file strategy, tender cycles, and the local-manufacture price preferences where your product qualifies.
Scientific engagement, medical information, and a named pharmacovigilance responsible person.
Launch planning, approved promotional material, and coverage of hospitals, clinics and retail pharmacy.
Import, customs clearance, validated cold chain, stock cover and recall readiness.
A clear, five-stage path — with realistic timelines at each step, and no promises we can't keep.
Product, competition and price band.
2–4 WeeksAgency terms and supply pricing.
4–8 WeeksDossier, testing, pricing committee.
10–18 MonthsTenders, hospitals, field coverage.
From Month OneLocal packaging, then the next GCC market.
Year TwoIndicative for Oman. We give a product-specific projection after the assessment, and we do not promise approval dates.
Through our partner and shareholder Opal Bio Pharma, a product packaged in Oman is treated as locally produced — and priced accordingly by the Ministry of Health. It does not require you to move primary manufacturing or transfer your process. Biotechnology lines follow over the next three years.
How local manufacturing worksAll three are under review by the Oman Ministry of Health. Below is where each one sits in the process, and what it will address.
All three products are under regulatory review by the Ministry of Health in the Sultanate of Oman and are not approved for sale. This page is intended for healthcare professionals and business partners, not the general public.
Send us the molecule and the markets where it is approved. We will tell you whether it has a route in Oman — including when the answer is no. We reply to every enquiry within three working days.